Portfolio company
Stratosvir
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Vivere Oncotherapies
This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.
Siren Bio
This company develops immuno-gene therapies combining viral gene delivery and cytokine immunotherapy to treat solid tumours for cancer patients.
Abalos Therapeutics
This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.
Theolytics
The company develops oncolytic viral immunotherapies for patients with solid tumours.
Cytospire Therapeutics
This company develops multispecific immune cell engager antibodies for cancer patients to enhance and direct immune system activity against solid tumours.
Ventuno Biotech
This biotechnology company develops cancer immunotherapies to stimulate the immune system and treat patients with difficult tumours.
Akamis Bio
This clinical-stage oncology company develops intravenously administered immunotherapies to treat solid tumours, specifically targeting patients living with colorectal cancer.
Oncorus
This company develops intravenous self-amplifying RNA medicines and viral immunotherapies for patients with solid tumours.
